Purple Biotech Ltd. (PPBT)
NASDAQ: PPBT
· Real-Time Price · USD
2.43
0.12 (5.19%)
At close: Aug 15, 2025, 3:59 PM
2.28
-6.17%
After-hours: Aug 15, 2025, 04:48 PM EDT
Purple Biotech Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 5.77M | 7.4M | 5.44M | 6.52M | 9.98M | 14.49M | 15.1M | 17.2M | 21.88M | 15.03M | 11.07M | 14.01M | 23.54M | 10.89M | 9.12M | 10.54M | 10.2M |
Short-Term Investments | 1.31M | 1.12M | 862K | 867K | 869K | 923K | 980K | 1.2M | 1.24M | 17.08M | 22.01M | 22.01M | 16.01M | 36.31M | 36.45M | 37.85M | 45.26M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 187K | 187K | 187K | 187K | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.64M | 2.64M | 2.66M | 160K | 5.02M | 5.02M | 3.07M |
Receivables | n/a | 275K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 500K | 500K | 500K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a |
Other Current Assets | 428K | 109K | 638K | 473K | 548K | 171K | 634K | 984K | 1.29M | 146K | 1.22M | 1.43M | 2.35M | 268K | 1.13M | 1.11M | 1.49M |
Total Current Assets | 7.51M | 8.91M | 6.94M | 7.86M | 11.4M | 15.79M | 16.72M | 19.38M | 24.41M | 33.26M | 34.31M | 37.45M | 41.9M | 48.47M | 47.2M | 50M | 57.44M |
Property-Plant & Equipment | 237K | 288K | 325K | 359K | 417K | 470K | 510K | 571K | 628K | 682K | 725K | 780K | 867K | 896K | 931K | 991K | 959K |
Goodwill & Intangibles | 27.84M | 27.84M | 27.84M | 27.84M | 28.04M | 28.04M | 28.04M | 28.04M | 28.04M | 20.68M | 20.68M | 20.68M | 20.68M | 20.48M | 20.48M | 20.48M | 20.48M |
Total Long-Term Assets | 28.08M | 28.13M | 28.17M | 28.2M | 28.46M | 28.51M | 28.55M | 28.61M | 28.67M | 21.37M | 24.24M | 24.29M | 24.39M | 21.73M | 26.43M | 26.49M | 24.51M |
Total Assets | 35.59M | 37.04M | 35.1M | 36.06M | 39.86M | 44.3M | 45.27M | 48M | 53.08M | 54.62M | 58.54M | 61.74M | 66.29M | 70.2M | 73.63M | 76.49M | 81.95M |
Account Payables | 868K | 1.46M | 1.91M | 3.04M | 3.48M | 3.53M | 2.59M | 1.57M | 2.45M | 2.13M | 2.77M | 1.23M | 1.65M | 1.47M | 2.08M | 2.07M | 1.33M |
Deferred Revenue | n/a | n/a | n/a | 2.15M | 2.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 411K | 1.15M | 1.56M | 1.1M | 2.05M | 673K | 3.45M | 3.12M | 2.98M | 698K | 2.98M | 3.97M | 5.34M | 611K | 1.14M | n/a | n/a |
Total Current Liabilities | 2.76M | 3.99M | 5.46M | 6.47M | 8.51M | 7.18M | 6.22M | 4.88M | 5.62M | 7.06M | 5.93M | 5.39M | 7.19M | 4.25M | 3.43M | 3.5M | 5.97M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 140K | 140K | 141K | 141K | 141K | 2.66M | 141K | 141K | 141K | 145K | 143K | 292K | 292K | 292K | 265K | 265K | 265K |
Total Long-Term Liabilities | 140K | 140K | 179K | 220K | 262K | 2.82M | 333K | 378K | 419K | 466K | 500K | 691K | 787K | 842K | 828K | 870K | 887K |
Total Liabilities | 2.9M | 4.13M | 5.64M | 6.69M | 8.77M | 10.01M | 6.55M | 5.25M | 6.04M | 7.52M | 6.43M | 6.08M | 7.97M | 5.09M | 4.25M | 4.37M | 6.86M |
Total Debt | 137K | 183K | 222K | 261K | 307K | 351K | 370K | 421K | 467K | 515K | 550K | 594K | 694K | 749K | 762K | 804K | 829K |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -145.15M | -144.69M | -144.28M | -143.62M | -141.22M | -137.45M | -132.63M | -127.59M | -122.45M | -117.58M | -111.56M | -106.74M | -103.2M | -95.91M | -90.83M | -87.7M | -84.07M |
Comprehensive Income | -98K | -98K | -98K | 37.34M | -98K | 10.01M | 10.18M | 9.93M | 10.6M | 10.06M | 9.69M | 9.18M | 8.89M | 8.76M | 9.67M | 9.27M | 8.73M |
Shareholders Equity | 32.65M | 32.86M | 29.41M | 29.32M | 31.02M | 34.21M | 38.6M | 42.6M | 46.88M | 46.91M | 51.89M | 55.41M | 58.06M | 64.83M | 69.06M | 71.8M | 74.75M |
Total Investments | 1.31M | 1.12M | 862K | 867K | 869K | 923K | 980K | 1.2M | 1.24M | 17.08M | 22.2M | 22.2M | 16.2M | 36.5M | 36.45M | 37.85M | 45.26M |